Provention Bio Inc $ 12.83 -1.82 (-12.42%)
Volume:
1,500,606
Avg Vol (1m):
1,037,478
Market Cap $:
804.93 Mil
Enterprise Value $:
657.77 Mil
PE Ratio:
0.00
PB Ratio:
5.35
Financial Strength | 7/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | No Debt | ||
Interest Coverage | No Debt | ||
Piotroski F-Score | 2 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -70.36 | ||
ROA % | -65.08 | ||
ROC (Joel Greenblatt) % | -22144.89 |
PRVB
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 5.35 | ||
EV-to-EBIT | -8.45 | ||
EV-to-EBITDA | -8.45 | ||
Current Ratio | 9.23 | ||
Quick Ratio | 9.23 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 5.35 | ||
Earnings Yield (Greenblatt) % | -11.85 |